Sign in
Not yet taking people in South KoreaNo phase

Pacing and AV junction ablation in end-stage heart failure with atrial fibrillation

Compares an ICD alone with an ICD plus pacing and ablation in these patients.

Key facts

Who runs it
Yonsei University
Where
Seoul, South KoreaSee the site
Trial code
Registry title
Conduction System Pacing and AV Junction Ablation in Heart Failure With Atrial Fibrillation (SYNC AF-HTx)
Status
Not yet recruiting
People taking part
120 people, planned
Started
Jan 2026
Expected to end
May 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • LBBP + AVJ Ablation with ICD
  • ICD Only
Record updated
12 January 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with end-stage heart failure and long-lasting atrial fibrillation who are considered for a heart transplant or an LVAD and need an ICD.

Age
19 years or older
Sex
All sexes
Disease stage
End-stage heart failure with permanent atrial fibrillation (longer than 6 months) that is not suited for catheter ablation or did not respond to it; LVEF 35 or lower within 6 weeks before enrollment; NYHA class II or higher
Earlier treatment
Guideline-directed medical therapy (GDMT) for at least 3 months

Main reasons for not taking part

  • Already has an LVAD or had a heart transplant
  • Needs cardiac resynchronization therapy (CRT)
  • Has had a mechanical tricuspid valve replacement
  • Expected survival of 12 months or less
  • Cannot follow the study protocol

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Candidates for ICD implantation (primary or secondary prevention). Permanent AF (>6 months) unsuitable for or failed catheter ablation. End-stage heart failure considering heart transplant or LVAD. LVEF ≤ 35 within 6 weeks before enrollment. NYHA functional class ≥ II. On GDMT for at least 3 months. Age ≥ 19 years

Who cannot take part

  • Existing LVAD or prior heart transplantation. Indications for cardiac resynchronization therapy (CRT). History of mechanical tricuspid valve replacement. Expected survival≤ 12 months. Inability to comply with the study protocol

Where in South Korea

  • Division of Cardiology, Yonsei University College of Medicine.Seoul, South KoreaContact: tae hoon kim, MD, PhDNot yet recruiting

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the safety and efficacy of conduction system pacing (CSP) using left bundle branch pacing (LBBP) and atrioventricular junction (AVJ) ablation in patients with end-stage heart failure and permanent atrial fibrillation (AF). Participants who are candidates for heart transplantation or left ventricular assist device (LVAD) implantation will be randomized to either the SYNC group (ICD implantation combined with LBBP and AVJ ablation) or the control group (ICD implantation only). The investigators will compare clinical outcomes, including mortality and heart failure hospitalization, between the two strategies over a 1-year follow-up period.

The 2 groups in the trial

  • SYNC groupTreatment being tested

    Combined procedure of ICD implantation, LBBP lead insertion, and AVJ ablation.

    Treatment: LBBP + AVJ Ablation with ICD

  • Control groupExisting treatment, for comparison

    Standard ICD implantation with minimal ventricular pacing strategy.

    Treatment: ICD Only

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Safety and efficacY of conductioN System paCing and Atrioventricular Junctional Ablation Combined With ICD Implantation in Patients With End-stage Heart Failure and Atrial Fibrillation Eligible for Heart Transplantation (SYNC AF-HTx) : Multicenter Prospective Randomized Controlled Trial
Plain-language title
Pacing and AV junction ablation in end-stage heart failure with atrial fibrillationGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
12 January 2026